Poi Tamrakar Tamrakar

Mrs. Poi Tamrakar Tamrakar

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2024
Verified
Book Chapter
Closed access
PDF file
PTPoi Tamrakar Tamrakar
Poi Tamrakar Tamrakar
GPGanesh R. Pathak
Ganesh R. Pathak
MLMily Lal
Mily Lal
AGAkanksha Goel
Akanksha Goel
MBManisha Bhende
Manisha Bhende

2 April 2026 in Discover Artificial Intelligence
Verified
Journal Article
Open access
PDF file
PTPoi Tamrakar Tamrakar
Poi Tamrakar Tamrakar
GPGanesh Pathak
Ganesh Pathak
The medical diagnostics and treatment have not helped to remove breast cancer as a significant health issue in the world. Risk stratification and informed clinical decision-making depend on accurate prediction of breast cancer outcomes. In this study, we propose a deep learning-based outcome prediction framework called as a Random Optimization based Fully Connected Neural Network (RObFCNN) for breast cancer outcome prediction. The proposed approach integrates a random optimization strategy for feature subset selection with a fully connected neural network, enabling effective modeling of complex and nonlinear relationships within high-dimensional clinical and genomic data. The publicly available METABRIC dataset was used to conduct experiments. Proposed RObFCNN framework’s performance was compared to the widely used machine learning models such as standard neural networks, Random Forests, Decision Trees, and Extreme Gradient Boosting. In the framework of this experiment, the accuracy of the proposed framework reached 95.28%, sensitivity 94.56%, specificity 95.73%, precision 93.29%, and Matthews Correlation Coefficient (MCC) 0.9006, which is better than the predictive performance of the considered baseline methods. The findings indicate that the RObFCNN framework is an effective research-level framework that can be used to model breast cancer prognostics based on optimized feature selection and deep learning. This should be further validated on independent datasets and a survival specific modeling methodology should be included to determine its generalizability and potential clinical applicability.